Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2025-12-24 @ 4:25 PM
Study NCT ID:
NCT03830866
Status:
COMPLETED
Last Update Posted:
2024-07-26
First Post:
2018-12-04
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-04
First Submit QC Date:
None
Study First Post Date:
2019-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-01-13
Results First Submit QC Date:
None
Results First Post Date:
2023-03-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-28
Last Update Post Date:
2024-07-26
Last Update Post Date Type:
ACTUAL